Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;76(9):941-947.
doi: 10.1001/jamapsychiatry.2019.0940.

Association Between Parental Medical Claims for Opioid Prescriptions and Risk of Suicide Attempt by Their Children

Affiliations

Association Between Parental Medical Claims for Opioid Prescriptions and Risk of Suicide Attempt by Their Children

David A Brent et al. JAMA Psychiatry. .

Abstract

Importance: The rate of youth suicide has increased over the past 15 years in the United States as has the rate of death due to opioid overdose in adults of parental age.

Objective: To explore the possible connection between parental use of prescription opioids and the increasing rate of youth suicide.

Design, setting, and participants: A pharmacoepidemiologic study was conducted from January 1, 2010, to December 31, 2016, linking medical claims for parental opioid prescriptions with medical claims for suicide attempts by their children. The study used MarketScan medical claims data covering more than 150 million privately insured people in the United States. The study included 121 306 propensity score-matched 30- to 50-year-old parents who used opioids and parents who did not use opioids and their 10- to 19-year-old children (148 395 children of parents who did not use opioids and 184 142 children of parents who used opioids). Propensity score matching was used to identify relevant control families based on demographic features and concomitant use of psychotropic medication.

Exposures: Opioid use in a parent was defined as having prescription fills covering more than 365 days of an opioid between 2010 and 2016.

Main outcomes and measures: Suicide attempt rate in the children of parents who used opioids and those who did not use opioids.

Results: A total of 148 395 children (75 575 sons and 72 820 daughters; mean [SD] age, 11.5 [1.6] years at the start of follow-up) had parents who did not use opioids and 184 142 children (94 502 sons and 89 640 daughters; mean [SD] age, 11.8 [1.8] years at the start of follow-up) with parents who did use opioids. There were 100 899 children aged 10 to 14 years and 47 496 children aged 15 to 19 years with parents who did not use opioids and 96 975 children aged 10 to 14 years and 87 163 children aged 15 to 19 years with parents who did use opioids. Of the children with parents who did not use opioids, 212 (0.14%) attempted suicide; of the children with parents who did use opioids, 678 (0.37%) attempted suicide. Parental use of opioids was associated with a doubling of the risk of a suicide attempt by their offspring (odds ratio [OR], 1.99; 95% CI, 1.71-2.33). The association remained significant after adjusting for child age and sex (OR, 1.85; 95% CI, 1.58-2.17), addition of child and parental depression and diagnoses of substance use disorder (OR, 1.46; 95% CI, 1.24-1.72), and addition of parental history of suicide attempt (OR, 1.45; 95% CI, 1.23-1.71). Geographical variation in opioid use did not change the association (OR, 2.00; 95% CI, 1.71-2.34).

Conclusions and relevance: Children of parents who use prescription opioids are at increased risk for suicide attempts, which could be a contributing factor to the time trend in adolescent suicidality. The care of families with a parent who uses opioids should include mental health screening of their children.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Brent reported receiving royalties from Guilford Press, eRT, and UpToDate and reported serving as a consultant for Healthwise and McKeeson (although in the latter, not related to issues of opioid abuse). Dr Gibbons reported being a founder of Adaptive Testing Technologies, which distributes the CAT-MH suite of computerized adaptive tests and reported serving as an expert witness in cases related to suicide for the US Department of Justice and Pfizer, Wyeth, and GSK. These activities have been reviewed and approved by the University of Chicago in accordance with its conflict of interest policies. No other disclosures were reported.

Comment in

Similar articles

Cited by

References

    1. Curtin SC, Tejada-Vera B, Warmer M. Drug overdose deaths among adolescents aged 15-19 in the United States: 1999-2015. NCHS Data Brief. 2017;(282):1-8. - PubMed
    1. Mercado MC, Holland K, Leemis RW, Stone DM, Wang J. Trends in emergency department visits for nonfatal self-inflicted injuries among youth aged 10 to 24 years in the United States, 2001-2015. JAMA. 2017;318(19):1931-1933. doi:10.1001/jama.2017.13317 - DOI - PMC - PubMed
    1. Lowry R, Crosby AE, Brener ND, Kann L. Suicidal thoughts and attempts among US high school students: trends and associated health-risk behaviors, 1991-2011. J Adolesc Health. 2014;54(1):100-108. doi:10.1016/j.jadohealth.2013.07.024 - DOI - PubMed
    1. Stone M, Laughren T, Jones ML, et al. . Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880. doi:10.1136/bmj.b2880 - DOI - PMC - PubMed
    1. Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry. 2009;66(6):633-639. doi:10.1001/archgenpsychiatry.2009.46 - DOI - PubMed

Publication types

MeSH terms

Substances